Detalhe da pesquisa
1.
Combination therapy with anti-HIV-1 antibodies maintains viral suppression.
Nature
; 561(7724): 479-484, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30258136
2.
Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity.
Nat Med
; 26(2): 222-227, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32015556
3.
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study.
PLoS One
; 14(8): e0219142, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31393868
4.
Clonal CD4+ T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation.
Nat Med
; 24(5): 604-609, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29686423
5.
Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117.
J Exp Med
; 215(9): 2311-2324, 2018 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30072495
6.
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals.
Nat Med
; 24(11): 1701-1707, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30258217